Antabuse: A Clinically Proven Deterrent for Alcohol Dependence
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.52 | $46.46 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $61.94 $57.57 (7%) | 🛒 Add to cart |
| 180 | $0.46 | $92.91 $82.82 (11%) | 🛒 Add to cart |
| 270 | $0.44 | $139.37 $119.17 (14%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $185.83 $154.52 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.96 | $57.57 (0%) | 🛒 Add to cart |
| 90 | $0.85 | $86.35 $76.76 (11%) | 🛒 Add to cart |
| 120 | $0.79 | $115.13 $94.93 (18%) | 🛒 Add to cart |
| 180 | $0.73 | $172.70 $131.29 (24%) | 🛒 Add to cart |
| 270 | $0.69 | $259.05 $186.84 (28%) | 🛒 Add to cart |
| 360 | $0.68
Best per pill | $345.40 $244.41 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a prescription medication used as an aversive therapy in the management of chronic alcohol use disorder. It functions by inducing an acutely unpleasant physical reaction upon alcohol consumption, thereby creating a powerful psychological deterrent to drinking. Administered under medical supervision, it is a cornerstone of comprehensive treatment plans that include counseling and behavioral support. This medication is intended for motivated individuals committed to maintaining sobriety as part of a structured recovery program.
Features
- Active ingredient: Disulfiram
- Available in 250 mg and 500 mg oral tablets
- Works by inhibiting the enzyme acetaldehyde dehydrogenase
- Requires a period of alcohol abstinence prior to initiation
- Prescription-only medication; not available over the counter
- Manufactured under strict pharmaceutical quality standards
Benefits
- Creates a strong physiological deterrent to alcohol consumption
- Supports long-term abstinence when combined with behavioral therapy
- Provides a tangible tool to help break the cycle of alcohol dependence
- Reduces cravings by associating alcohol with highly unpleasant effects
- Empowers patients to take active control of their recovery journey
- Can be used as part of a comprehensive addiction treatment program
Common use
Antabuse is primarily prescribed for the management of chronic alcohol use disorder in patients who want to remain in a state of enforced sobriety. It is typically used after detoxification when the patient has achieved initial abstinence. The medication is most effective when incorporated into a complete treatment program that includes psychological support, counseling, and participation in support groups. Healthcare providers prescribe Antabuse for motivated patients who understand the consequences of alcohol consumption while taking the medication and who have made a conscious decision to maintain abstinence.
Dosage and direction
The initial dosage is typically 500 mg daily for one to two weeks, followed by a maintenance dose of 250 mg daily (range 125-500 mg). The dosage should be individually adjusted based on patient response and tolerance. Administration is usually in the morning, but may be divided if sedation occurs. The tablet should be swallowed whole with water, preferably at the same time each day. Treatment should not be initiated until the patient has abstained from alcohol for at least 12 hours. Regular medical supervision is essential throughout treatment.
Precautions
Patients must be fully informed about the Antabuse-alcohol reaction and must avoid all forms of alcohol, including medications, foods, and toiletries containing alcohol. Regular liver function tests are required due to potential hepatotoxicity. Use with caution in patients with diabetes, hypothyroidism, epilepsy, cerebral damage, chronic or acute nephritis, hepatic cirrhosis, or hepatic insufficiency. Patients should carry identification indicating they are taking Antabuse. The disulfiram-ethanol reaction may occur for up to 14 days after the last dose.
Contraindications
Antabuse is contraindicated in patients with severe myocardial disease or coronary occlusion, psychoses, hypersensitivity to disulfiram or other thiuram derivatives, and those who are in a state of alcohol intoxication. It should not be given to patients who have recently taken metronidazole, paraldehyde, alcohol, or alcohol-containing preparations. Contraindicated in pregnancy unless clearly necessary and with thorough risk-benefit assessment. Not recommended for patients without their full knowledge or consent.
Possible side effects
Common side effects include drowsiness, fatigue, headache, metallic or garlic-like aftertaste, skin eruptions, and impotence. Less frequently reported effects include optic neuritis, peripheral neuritis, polyneuritis, and hepatic toxicity. In the absence of alcohol consumption, these effects are generally mild and often diminish with continued therapy. The most significant adverse effect is the disulfiram-ethanol reaction, characterized by flushing, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion.
Drug interaction
Antabuse potentiates the effects of warfarin and other oral anticoagulants, requiring dosage adjustment and frequent monitoring. It may increase blood levels of phenytoin, benzodiazepines, tricyclic antidepressants, and theophylline. Concurrent use with alcohol-containing preparations (including some cough syrups, tonics, and vinegars) will provoke a reaction. Interaction with metronidazole may cause confusion and psychosis. Antabuse inhibits various hepatic enzymes, potentially affecting metabolism of multiple medications including certain anticonvulsants and barbiturates.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Patients should maintain regular contact with their healthcare provider to ensure consistent dosing and treatment efficacy. Irregular dosing may compromise the deterrent effect and treatment outcomes.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, ataxia, seizures, and unconsciousness. In severe cases, overdose can lead to respiratory depression, cardiovascular collapse, and coma. Management is supportive and symptomatic. There is no specific antidote. Gastric lavage may be considered if performed soon after ingestion. Activated charcoal may be administered. Hospitalization with monitoring of vital signs, electrolyte balance, and hepatic function is recommended in cases of significant overdose.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place, protected from light. Keep in the original container with the lid tightly closed. Do not store in bathroom or kitchen where moisture levels may vary. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication according to specific disposal instructions or medication take-back programs.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Antabuse is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary. Patients should consult with their healthcare provider for personalized medical advice, including potential risks and benefits specific to their situation. Never initiate or discontinue medication without professional medical guidance.
Reviews
Clinical studies demonstrate that Antabuse, when used as part of a comprehensive treatment program, significantly improves abstinence rates compared to placebo. Many addiction specialists report that motivated patients who fully understand the medication’s mechanism achieve better long-term outcomes. Patient experiences vary, with some reporting the medication provides crucial support during early recovery, while others find the required lifestyle adjustments challenging. Success appears highest when combined with ongoing counseling and support network engagement.